The performance of companies tied to Sildenafil's legacy presents a intricate investment landscape. While the initial boom generated substantial gains, generic competition have significantly eroded sales . https://maximusbookmarks.com/story21704939/copyright-s-flagship-product-and-big-pharma-a-uncertain-venture